A molecular model of the human UDP-glucuronosyltransferase 1A1, its membrane orientation, and the interactions between different parts of the enzyme
- PMID: 20215562
- DOI: 10.1124/mol.109.063289
A molecular model of the human UDP-glucuronosyltransferase 1A1, its membrane orientation, and the interactions between different parts of the enzyme
Abstract
The vertebrate UDP-glucuronosyltransferases (UGTs) are membrane-bound enzymes of the endoplasmic reticulum that process both endogenous and exogenous substrates. The human UGTs are well known biologically, but biophysical understanding is scarce, largely because of problems in purification. The one resolved crystal structure covers the C-terminal domain of the human UGT2B7. Here, we present a homology model of the complete monomeric human UGT1A1, the enzyme that catalyzes bilirubin glucuronidation. The enzyme can be seen as composed of four different domains: two large ones, the N- and C-terminal domains, and two small ones, the "envelope" helices and the transmembrane segment that includes the cytoplasmic tail. The hydrophobic core of the N-terminal domain and the two envelope helices that connect the large domains are shown to be structurally well conserved even among distant homologs and can thus be modeled with good certainty according to plant and bacterial structures. We consider alternative solutions for the highly variable N-terminal regions that probably contribute to substrate binding. The bilirubin binding site, known pathological mutations in UGT1A1, and other specific residues have been examined in the context of the model with regard to available experimental data. A putative orientation of the protein relative to the membrane has been derived from the location of predicted N-glycosylation sites. The model presents extensive interactions between the N- and C-terminal domains, the two envelope helices, and the membrane. Together, these interactions could allow for a concerted large-scale conformational change during catalysis.
Similar articles
-
The first aspartic acid of the DQxD motif for human UDP-glucuronosyltransferase 1A10 interacts with UDP-glucuronic acid during catalysis.Drug Metab Dispos. 2008 Mar;36(3):517-22. doi: 10.1124/dmd.107.016469. Epub 2007 Nov 29. Drug Metab Dispos. 2008. PMID: 18048489 Free PMC article.
-
Role of cysteine residues in the function of human UDP glucuronosyltransferase isoform 1A1 (UGT1A1).Biochem J. 2005 Dec 15;392(Pt 3):685-92. doi: 10.1042/BJ20050381. Biochem J. 2005. PMID: 16171463 Free PMC article.
-
Protein-protein interactions between the bilirubin-conjugating UDP-glucuronosyltransferase UGT1A1 and its shorter isoform 2 regulatory partner derived from alternative splicing.Biochem J. 2013 Feb 15;450(1):107-14. doi: 10.1042/BJ20121594. Biochem J. 2013. PMID: 23148825
-
Understanding substrate selectivity of human UDP-glucuronosyltransferases through QSAR modeling and analysis of homologous enzymes.Xenobiotica. 2012 Aug;42(8):808-20. doi: 10.3109/00498254.2012.663515. Epub 2012 Mar 2. Xenobiotica. 2012. PMID: 22385482 Free PMC article. Review.
-
Structural and functional studies of UDP-glucuronosyltransferases.Drug Metab Rev. 1999 Nov;31(4):817-99. doi: 10.1081/dmr-100101944. Drug Metab Rev. 1999. PMID: 10575553 Review.
Cited by
-
Characterization of UDP-glucuronosyltransferase 2A1 (UGT2A1) variants and their potential role in tobacco carcinogenesis.Pharmacogenet Genomics. 2011 Feb;21(2):55-65. doi: 10.1097/FPC.0b013e328341db05. Pharmacogenet Genomics. 2011. PMID: 21164388 Free PMC article.
-
1H, 13C and 15N chemical shift assignments of the C-terminal domain of human UDP-Glucuronosyltransferase 2B7 (UGT2B7-C).Biomol NMR Assign. 2021 Oct;15(2):323-328. doi: 10.1007/s12104-021-10024-9. Epub 2021 Apr 18. Biomol NMR Assign. 2021. PMID: 33870481 Free PMC article.
-
Machine learning and structure-based modeling for the prediction of UDP-glucuronosyltransferase inhibition.iScience. 2022 Oct 6;25(11):105290. doi: 10.1016/j.isci.2022.105290. eCollection 2022 Nov 18. iScience. 2022. PMID: 36304105 Free PMC article.
-
Recent progress and challenges in screening and characterization of UGT1A1 inhibitors.Acta Pharm Sin B. 2019 Mar;9(2):258-278. doi: 10.1016/j.apsb.2018.09.005. Epub 2018 Sep 14. Acta Pharm Sin B. 2019. PMID: 30972276 Free PMC article. Review.
-
The regioselective glucuronidation of morphine by dimerized human UGT2B7, 1A1, 1A9 and their allelic variants.Acta Pharmacol Sin. 2017 Aug;38(8):1184-1194. doi: 10.1038/aps.2016.157. Epub 2017 May 29. Acta Pharmacol Sin. 2017. PMID: 28552915 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources